Unprecedented Access to Experimental Obesity Drug Raises Questions
The granting of special access to an experimental obesity drug for an unidentified individual is an unusual occurrence that prompts scrutiny.
Editorial Staff about 16 hours ago
3 articles tagged with "GLP-1"
The granting of special access to an experimental obesity drug for an unidentified individual is an unusual occurrence that prompts scrutiny.
Recent mid-stage trials indicate that AstraZeneca's GLP-1 pill may offer benefits for obesity and diabetes, although its effectiveness compared to other treatments is still unclear.
Recent research suggests that GLP-1 medications may not only aid in weight loss and diabetes management but also reduce the risk of substance use disorders and breast cancer in women.